Grass pollen

Miller, A. C. M. L., and Tees, E. C., A metabolizable adjuvant Clinical trial of grass pollen-tyrosine adsorbate, Clin. Allergy. 4, 49-55, 1974. [Pg.228]

Francis JN, Till SJ, Durham SR Induction of 1L-10+CD4+CD25+ T cells by grass pollen immunotherapy. J Allergy Clin Immunol 2003 111 1255-1261. Jutel M, Akdis M, Budak F, Aebischer-Casaulta C. Wrzyszcz M, Blaser K, Akdis CA lL-10 and TGF-P cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 2003 33 1205-1214. [Pg.42]

Nouri-Aria KT. Wachholz PA. Francis JN. Jacobson MR, Walker SM. Wilcock LK. Staple SQ, Aalberse RC, Till SJ. Durham SR Grass pollen immunother-apyinduces mucosal and peripheral IL-10 responses and blocking IgG activity. J Immunol 2004 172 3252-3259. [Pg.42]

Pilette C. Nouri-Aria KT. Jacobson MR. Wilcock LK, Detry B. Walker SM. Francis JN. Durham SR Grass pollen immunotherapy induces an allergen-specific IgA2 antibody response associated with mucosal TGF-P expression. J Immunol 2007 178 4658-4666. [Pg.42]

Varney VA. Hamid QA. Gaga M. Ying S. Jacobson M, Frew AJ. Kay AB. Durham SR Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. J Clin Invest 1993 92 644-651. [Pg.42]

Radulovic S. Jacobson MR. Durham SR. Nouri-Aria KT Grass pollen immunotherapy induces Foxp3-expressing CD4+ CD25+ cells in the nasal mucosa. J AUergy Clin Immunol 2008 121 1467-1472. 1472 el461. [Pg.42]

Jutel M, Jaeger L, Suck R, Meyer H, Fiebig H, Cromwell O Allergen-specific immunotherapy with recombinant grass pollen allergens. J Allergy Clin Immunol 2005 116 608-613. [Pg.43]

Salih, A., Jones, A., Bass, D. and Cox, G. (1997). Confocal imaging of exine for grass pollen analysis. Grana 36 215-224. [Pg.123]

Grass pollen Increase IL-10 production in CD4+CD25+ Treg... [Pg.154]

Francis JN. Till SJ, Durham SR Induction ofIL-10+CD4+CD25+ T cells by grass pollen immunotherapy. J Allergy Clin Immunol 2003 111 1255-1261. [Pg.157]

Walker SM, Varney VA, Gaga M, Jacobson MR, Durham SR Grass pollen immunotherapy efficacy and safety during a 4-year follow-up study. Allergy 1995 50 405-413. [Pg.173]

Durham SR, Walker SM, Varga EM, Jacobson MR, O Brien F, Noble W, et al Long-term chnical efficacy of grass-pollen immunotherapy. N Engl J Med... [Pg.173]

Flicker S, Steinberger P, Norderhaug L, Sperr WR, Majlesi Y, Valent P, et al Conversion of grass pollen allergen-specific human IgE into a protective IgGl antibody. Eur J Immunol 2002 32 2156-2162. [Pg.173]

Hay fever is the inflammatory reaction to inhaling pollen, especially grass pollen. Symptoms include copious secretions of mucus in the nose, and itchy and watery eyes. The pollen grains enter interstitial fluid through the mucous membranes and initiate secretion of IgE antibodies. On the next exposure to pollen, the grains bind to the IgE... [Pg.399]

Roder E, Berger MY, Hop WC, Bernsen RM, de Groot H, Gerth van Wijk R. Sublingual immunotherapy with grass pollen is not effective in symptomatic youngsters in primary care. J Allergy Clin Immunol 2007 119(4) 892-8. [Epub 2007 Feb 23]. [Pg.657]

Table 3. Double-blind placebo controlled sublingual studies grass pollen... [Pg.5]

Clavel R, Andre C, Bousquet J Reduction of corticosteroid therapy by sublingual immunotherapy. Double blind study against placebo of standardised 5 grass pollen extract in rhinitis. Allergy 1995 50/26 279. [Pg.9]

Pradalier A, Basset D, Claudel A, Couturier P, Wessel F, Galvain S, Andre C Sublingual-swallow immunotherapy (SLIT) with a standardized five-grass-pollen extract (drops and sublingual tablets) versus placebo in seasonal rhinitis. Allergy 1999 54 819-828. [Pg.9]

Fanta C, Bohle B, Hirt W, Siemann U, Horak F, Kraft D, Ebner H, Ebner C Systemic immunological changes induced by administration of grass pollen allergens via the oral mucosa during sublingual immunotherapy. Int Arch Allergy Immunol 1999 120 218-224. [Pg.9]

Di Rienzo Y Puccinelli P, Frati F, Parmiani S Grass pollen specific sublingual/swallow immunotherapy in children Open-controlled comparison among different treatment protocols. Allergol Immunopathol 1999 27/3 145—151. [Pg.9]

Hordijk GJ, Antvelink JB, Luwema RA Sublingual immunotherapy with a standardised grass pollen extract a double-blind placebo-controlled study. Allergol Immunopathol 1998 26/5 ... [Pg.9]

Clavel R, Bousquet J, Andre C Clinical efficacy of sublingual-swallow immunotherapy A double-blind, placebo-controlled trial of standardized five-grass-pollen extract in rhinitis. Allergy... [Pg.9]

Dolz I, Martinez-Cocera C, Bartolome J A double-blind, placebo-controlled study of immunotherapy with grass-pollen extract Alutard SQ during a 3-year period with initial rush immunotherapy. Allergy 1996 51 489-500. [Pg.10]

Marcucci F, Sensi L, Frati F, Senna GE, Canonica GW, Parmiani S, Passalacqua G Sublingual tryptase and ECP in children treated with grass pollen sublingual immunotherapy (SLIT) Safety and immunologic implications. Allergy 2001 56 1091-1095. [Pg.10]

Quirino T, Iemoli E, Siciliani S, Parmiani S, Milazzo F Sublingual versus injective immunotherapy in grass pollen allergic patients A double blind (double dummy) study. Clin Exp Allergy 1996 26 1253-1261. [Pg.10]

Based on the fact that many allergic patients are sensitized to several unrelated allergens, tolerance induction with a panel of simultaneously applied allergens is a desirable goal. We have established a model of polysensitization to major allergens of birch and grass pollen. Intranasal tolerance with a mixture of the immunodominant peptides of the three allergens led to a marked decrease of humoral and cellular Th2-like immune responses [67], Production of hybrid... [Pg.19]

Hufhagl K, Winkler B, Focke M, Baier K, Valenta R, Kraft D, Wiedermann U Induction of mucosal tolerance by coapplication of recombinant Bet v 1, the major birch pollen allergen, recombinant Phi p 1 and Phi p 5, major grass pollen allergens, in polysensitized mice. Allergy 2002 57(suppl 73) 49. [Pg.24]

Sabbah A, Hassoun S, Le Sellin J, Andre C, Sicard H A double blind placebo controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract. Allergy 1994 49 309-313. [Pg.42]

Igea JM, Cuevas M, Lazaro M, Quirce S, Cuesta J Susceptibility of a grass-pollen oral immunotherapy extract to the saliva and gastric fluid digestive process. Allergol Immunopathol... [Pg.43]

Efficacy of Sublingual Immunotherapy in Grass Pollen Allergy... [Pg.53]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...